Cognition Therapeutics CGTX
NASDAQ CGTX
$0.68 +0.01 (+1.06%)
At close: Nov 11, 2026 · 4:00 PM EST

Cognition Therapeutics (CGTX) Amortization of Deferred Charges (2020 - 2021)

Updated

Analysis

Cognition Therapeutics (CGTX) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cognition Therapeutics 63.72 Mn -68.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 92,000.00
Mar 31, 2021 260,000.00
Dec 31, 2020 246,000.00
Sep 30, 2020 228,000.00
API Access

Cognition Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CGTX&period=max&api_key=YOUR_API_KEY